Newstral
Article
Ars Technica on 2020-10-15 22:01
Russia approves second COVID-19 vaccine without data, clinical trials
Related news
- PRussia approves Covid-19 vaccine without completing phase three clinical trialspendect.com
- China says it began public use of COVID-19 vaccine a month ago, bypassing clinical trialsSeattle Times
- Russia Says It Started Producing Virus Vaccine, Saudis to Conduct Clinical TrialsHaaretz
- China Approves Coronavirus Vaccine Candidate Without Publishing Clinical Trial Databreitbart.com
- Russia Approves Second Covid-19 Vaccine — Before Phase-III Trials Even StartForbes
- Iran-Cuba vaccine to complete clinical trials by mid-Junetehrantimes.com
- Coronavirus: Russia completes clinical trials of second potential vaccineThe Jerusalem Post (JPost.com)
- Venezuela Starts Clinical Trials for Russian Coronavirus Vaccine Candidatebreitbart.com
- Russia starts clinical trials of COVID-19 vaccineSeattle Times
- FRussia’s Sputnik vaccine shows 91% efficacy in clinical trialsft.com
- Iran-Cuba vaccine enters phase three clinical trialstehrantimes.com
- Russian university completes clinical trials of COVID-19 vaccinetribuneonlineng.com
- China approves coronavirus vaccine for clinical trialsThe Jerusalem Post (JPost.com)
- TRussia approves virus vaccinethepostandmail.com
- Loss Of Clinical Trials In Russia’s Invasion Of UkraineForbes
- HChina Sinopharm’s Potential COVID-19 Vaccine Triggers Antibodies in Clinical Trialshamodia.com
- Russia: clinical trials for one-shot Sputnik Light vaccine are completeThe Jerusalem Post (JPost.com)
- Mysuru-based JSS Academy to carry out clinical trials for Novavax COVID-19 vaccineThe Hindu
- Russia’s Covid Vaccine Candidate Sputnik V to Have Clinical Trials in Indiatntribune.com
- Philippines eyes clinical trials for Russian COVID-19 vaccine in OctoberThe Jerusalem Post (JPost.com)